Please find enclosed copies of newspaper cuttings of the extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics Ltd has submitted newspaper cuttings of its unaudited Q2 and H1 FY26 financial results (period ended September 30, 2025), approved by the Board on November 14, 2025. Total income from operations for Q2 FY26 stood at Rs. 610.64 lakhs, down from Rs. 825.74 lakhs in Q2 FY25, while H1 FY26 income came in at Rs. 1,488.13 lakhs versus Rs. 1,687.64 lakhs in H1 FY25, indicating a year-on-year revenue decline. The company reported a net loss after tax of about Rs. 57.35 lakhs in Q2 FY26 and Rs. 276.74 lakhs in H1 FY26, continuing its loss-making streak with widening losses versus the prior year. Two key corporate actions were disclosed: voluntary winding up of its 51% subsidiary GSV Ophthalmic Private Limited, and the transfer of the optical business on a slump sale basis effective November 1, 2025 (approved by the Board on October 22, 2025).
The results are weak — falling revenue and continued losses mean little near-term positive catalyst for shareholders, while the slump-sale transfer of the optical business and winding up of the subsidiary signal a restructuring that could reshape the company's future profile but adds uncertainty for current investors.